Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Journal of the National Cancer Institute|August 22, 2025
The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLCMargaux Wooster, Michael May, Prashasti Agrawal, et al.Cell Reports. Medicine|December 13, 2022
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitorsShoiab Bukhari, Brian S Henick, Robert J Winchester, et al.Journal of Personalized Medicine|May 27, 2025
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late MetastasesMichelle Garlin Politis, Mahesh Mansukhani, Benjamin O Herzberg, et al.Journal for Immunotherapy of Cancer|December 25, 2024
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findingsBrian S Henick, Peter D Koch, Justin F Gainor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell AnalysisIla Datar, Miguel F Sanmamed, Jun Wang, et al.Nature Genetics|January 9, 2023
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimensYiping Wang, Joy Linyue Fan, Johannes C Melms, et al.Journal for Immunotherapy of Cancer|June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumorsKristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.Nature Medicine|March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim resultsAmy R Rappaport, Chrisann Kyi, Monica Lane, et al.Nature Genetics|April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.Nature Medicine|August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D Palmer, Amy R Rappaport, Matthew J Davis, et al.Pageof 4